This individual will join the biological sciences group to focus on the development of
novel cancer biological immunotherapies; monitor current technological developments in antibody, antibody drug conjugates and other protein cancer immunotherapies.
Identify potential problems or opportunities in the context of project teams to facilitate
advancement of product candidates; provide analytical support for upstream, downstream and conjugation process development activities.
The candidate will be responsible for developing cell culture medium, feeding strategies, process parameter optimization,and scale-up to support R&D,large scale production, pre-clinical, and clinical activities.
Ambrx is a bio pharmaceutical company enabling a new field of protein medicinal chemistry,using a fundamentally new technology that directs incorporation of amino acids beyond nature's conserved set into bio synthetic proteins to produce high value biologics products.